BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Diagnosis
28 results:

  • 1. Childhood cancer survival in the highly vulnerable population of South Texas: A cohort study.
    Wu S; Liu Y; Williams M; Aguilar C; Ramirez AG; Mesa R; Tomlinson GE
    PLoS One; 2023; 18(4):e0278354. PubMed ID: 37022991
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies.
    Illiano M; Colinard M; Taque S; Mallon B; Larue C; Laithier V; Vérité-Goulard C; Sudour-Bonnange H; Faure-Conter C; Coze C; Aerts I; De Maricourt CD; Paillard C; Branchereau S; Brugières L; Fresneau B
    Hepatol Int; 2022 Feb; 16(1):125-134. PubMed ID: 34506008
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.
    Rosenthal SH; Gerasimova A; Ma C; Li HR; Grupe A; Chong H; Acab A; Smolgovsky A; Owen R; Elzinga C; Chen R; Sugganth D; Freitas T; Graham J; Champion K; Bhattacharya A; Racke F; Lacbawan F
    PLoS One; 2021; 16(4):e0243683. PubMed ID: 33909614
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular response to imatinib in patients with chronic myeloid leukemia in Tanzania.
    Nasser A; Hussein A; Chamba C; Yonazi M; Mushi R; Schuh A; Luzzatto L
    Blood Adv; 2021 Mar; 5(5):1403-1411. PubMed ID: 33666650
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Efficacy and safety of hepatitis B re-vaccination in children after completion of chemotherapy and(or) hematopoietic stem cell transplantation].
    Yuan Q; Zhou F; Zhang H; Cao Q; Chen WJ; Fei Y; Luo CY; Gao YJ
    Zhonghua Er Ke Za Zhi; 2020 Oct; 58(10):802-806. PubMed ID: 32987458
    [No Abstract]    [Full Text] [Related]  

  • 6. Metalearning approach for leukemia informative genes prioritization.
    Rodrigues V; Deusdado S
    J Integr Bioinform; 2020 May; 17(1):. PubMed ID: 32383690
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiological Aspects and Risk Factors].
    Ouldamer L; Body G; Daraï E; Bendifallah S
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):239-247. PubMed ID: 32004787
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Sukswai N; Aung PP; Yin CC; Li S; Wang W; Wang SA; Ortega V; Lyapichev K; Nagarajan P; Alfattal R; Angelova E; Tang Z; Loghavi S; Kanagal-Shamanna R; Miranda RN; Pemmaraju N; Bhalla K; Konopleva M; Medeiros LJ; Khoury JD
    Am J Surg Pathol; 2019 Oct; 43(10):1429-1437. PubMed ID: 31261288
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Friend leukemia virus integration 1 is a predictor of poor prognosis of breast cancer and promotes metastasis and cancer stem cell properties of breast cancer cells.
    Yan X; Yu Y; Li L; Chen N; Song W; He H; Dong J; Liu X; Cui J
    Cancer Med; 2018 Aug; 7(8):3548-3560. PubMed ID: 29869379
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Monoclonal B-cell lymphocytosis in blood donors in Turkey.
    Yağcı M; Yegin ZA; Yenicesu İ; Suyanı E; Ulu BU; İnci K; Çetin Z; Yılmaz Z; Kurşunoğlu N; Özkurt ZN
    Hematology; 2018 Jan; 23(1):25-29. PubMed ID: 28583051
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B-cell acute leukemia.
    Ishizawa J; Sugihara E; Kuninaka S; Mogushi K; Kojima K; Benton CB; Zhao R; Chachad D; Hashimoto N; Jacamo RO; Qiu Y; Yoo SY; Okamoto S; Andreeff M; Kornblau SM; Saya H
    Blood; 2017 Apr; 129(14):1958-1968. PubMed ID: 28143883
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Aberrant methylation of protocadherin 17 and its prognostic value in pediatric acute lymphoblastic leukemia.
    Uyen TN; Sakashita K; Al-Kzayer LF; Nakazawa Y; Kurata T; Koike K
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27643535
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Molecular diagnosis of Toxoplasma gondii infection in Libya.
    Gashout A; Amro A; Erhuma M; Al-Dwibe H; Elmaihub E; Babba H; Nattah N; Abudher A
    BMC Infect Dis; 2016 Apr; 16():157. PubMed ID: 27083153
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. WT1 Expression in Circulating RNA as a Minimal Residual Disease Marker for AML Patients After Stem-Cell Transplantation.
    Zhong L; Wei L; Chen J; Huang X; Gong Y; Lu Y
    Mol Diagn Ther; 2015 Aug; 19(4):205-12. PubMed ID: 26138637
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mutant Enrichment with 3'-Modified Oligonucleotides (MEMO)-Quantitative PCR for Detection of NPM1 Mutations in Acute Myeloid leukemia.
    Shin SY; Ki CS; Kim HJ; Kim JW; Kim SH; Lee ST
    J Clin Lab Anal; 2015 Sep; 29(5):361-5. PubMed ID: 25384962
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Unraveling the complexity of hepatitis B virus: from molecular understanding to therapeutic strategy in 50 years.
    Liu B; Wen X; Huang C; Wei Y
    Int J Biochem Cell Biol; 2013 Sep; 45(9):1987-96. PubMed ID: 23819994
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS.
    Katzmann JA; Clark R; Kyle RA; Larson DR; Therneau TM; Melton LJ; Benson JT; Colby CL; Dispenzieri A; Landgren O; Kumar S; Bradwell AR; Cerhan JR; Rajkumar SV
    Leukemia; 2013 Jan; 27(1):208-12. PubMed ID: 22781594
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
    Björkholm M; Derolf AR; Hultcrantz M; Kristinsson SY; Ekstrand C; Goldin LR; Andreasson B; Birgegård G; Linder O; Malm C; Markevärn B; Nilsson L; Samuelsson J; Granath F; Landgren O
    J Clin Oncol; 2011 Jun; 29(17):2410-5. PubMed ID: 21537037
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
    Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
    Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.